Bogdan Petrunov
Overview
Explore the profile of Bogdan Petrunov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nikolov G, Todordova Y, Emilova R, Hristova D, Nikolova M, Petrunov B
Antibodies (Basel)
. 2021 Dec;
10(4).
PMID: 34940001
(1) Background: Biomarkers of efficacy for subcutaneous immunotherapy (SCIT) on allergic rhinitis have not been evaluated in details. The present study aims to assess the relevance of measuring of sIgE,...
2.
Kerekov N, Michova A, Muhtarova M, Nikolov G, Mihaylova N, Petrunov B, et al.
Immunobiology
. 2013 Sep;
219(1):45-52.
PMID: 24021574
House dust mites Dermatophagoides pteronyssinus (Dpt) are among the most frequent causes of allergy symptoms in Europe. Der p 1 is one of the major allergenic compounds of Dpt and...
3.
Seghrouchni F, Contini S, Markova R, Drenska R, Sadki K, Baassi L, et al.
Tuberculosis (Edinb)
. 2009 May;
89(3):210-7.
PMID: 19447677
In vitro diagnosis of MTB-infection uses MTB-proteins coded for by genes of the region of differentiation 1 (RD1) of the MTB genome. This study wants to test if proteins preferentially...
4.
Nikolova M, Stankulova D, Taskov H, Nenkov P, Maximov V, Petrunov B
Int Immunopharmacol
. 2009 Feb;
9(4):425-32.
PMID: 19186221
Respivax (BulBio-NCIPD Ltd.) is an oral polybacterial immunomodulator intended for treatment and prevention of non-specific respiratory tract infections. We studied for the first time its effects on the inductive mechanisms...
5.
Petrunov B, Marinova S, Markova R, Nenkov P, Nikolaeva S, Nikolova M, et al.
Int Immunopharmacol
. 2006 May;
6(7):1181-93.
PMID: 16714223
The oral polybacterial immunomodulator Dentavax (D), composed of killed cells from Klebsiella pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, Candida albicans and Lactobacillus acidophilus and their lysates was created for immunoprophylaxis and...